|
|
 |
Trial Information
Summary: Alzheimer’s Disease in Adults 50 and over
People with dementia resulting from Alzheimer’s Disease are
asked to participate in a research study being conducted by Litwin
Zucker Research Center.
You may be eligible to participate in this study if
you:
- Are Male or female at least 50 years of age
- Be on a stable dose of acetyl cholinesterase medication
(Aricept®, Reminyl® (Razadyne®) or Exelon®)
- Must be able to undergo MRI scans
- Have a reliable caretaker who will accompany you to all study
visits
You may not participate in this study if
you:
- Have had Parkinson’s Disease, seizure disorder, or a head
injury with loss of consciousness within the past 5 years
- Have schizophrenia or post-traumatic stress disorder
- Have participated in another research study within the last 30
days
|
Contact:
Erica Christen, Study Coordinator
Biomedical Research Alliance of New York
Litwin Zucker Research Center
225 Community Drive
Suite 110
Great Neck, NY 11021
Telephone: 516-487-3492
Fax: 516-487-3792
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:45:52 AM
|
 |
|